50
Participants
Start Date
November 30, 2004
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Curcumin
Starting dose 8 gm orally per day for 8 weeks. If patient experiences grade III toxicity, dose held and restarted with a 50% dose reduction after resolution of toxicity to \</= Grade I. Patients with grade IV toxicity will discontinue treatments. Patients with \</= grade I toxicity may have a 25% dose increase at each four-week period. Patients will continue on treatment until disease progresses, unless Grade III toxicity supervenes.
UT MD Anderson Cancer Center, Houston
Sabinsa Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER